Biochemical Engineering Special Interest Group
biological engineering professionals
05 December 2016

ReNeuron stem cell test helps mobility in stroke patients but misses endpoint

British biotech ReNeuron has posted generally encouraging midstage data which showed their stem cell therapy could help certain stroke patients move their arms better after being left disabled by their condition. Despite not hitting its primary endpoint, it is still plotting a pivotal test starting next year. Its CTX cell therapy candidate was being tested in a small phase 2 trial, known as Pisces II, that worked as a single-arm, open-label study in patients living with disability resulting from ischemic stroke. Source: Fierce Biotech 5/12/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).